Memantine hydrochloride
Description
Memantine hydrochloride (CAS 41100-52-1) is the salt form of memantine, an NMDA receptor antagonist active pharmaceutical ingredient used in the treatment of moderate-to-severe Alzheimer's disease. Supplied as a finished API or pharmaceutical intermediate, it is a primary target for generic drug manufacturers and contract formulators sourcing for solid oral dosage development.
Generic pharmaceutical manufacturers use this material as the active ingredient in immediate-release and extended-release tablet formulations indicated for cognitive decline disorders. Contract development organizations source it as a reference standard or bulk API for bioequivalence studies and formulation development against branded products in the marketplace.
It is also procured by compounding pharmacies requiring a documented API for patient-specific preparations. Research institutions source pharmaceutical-grade material for investigational use. Memantine hydrochloride is available as a white crystalline powder in bulk quantities ranging from laboratory-scale to commercial API lots for global distribution and manufacturing.
Standard supply grades include USP, EP (Ph. Eur.), and in-house pharmaceutical grades with full ICH-compliant documentation packages for regulatory submission. Certificates of Analysis, DMF references, and impurity profiles are standard documentation expectations for this material in regulated markets to ensure safety and compliance.
Other Names (Synonyms)
memantine.HCl|3,5-dimethyltricyclo(3.3.1.1(3,7))decan-1-amine hydrochloride|3,5-dimethyladamantan-1-aminium chloride|3,5-Dimethyl-1-adamantanamine hydrochloride|1-Amino-3,5-dimethyladamantane hydrochloride|3,5-dimethyladamantan-1-amine hydrochloride|Akatinol|Namenda XR
Key Technical Features
- High Purity Grade standard
- Consistent Batch Quality
- Full Regulatory & REACH Support
- Global Logistics Network enabled